EAM
Erste Asset Management Portfolio holdings
AUM
$11.9B
1-Year Return
22.95%
This Quarter Return
+8.41%
1 Year Return
+22.95%
3 Year Return
+112.82%
5 Year Return
+205.55%
10 Year Return
–
AUM
$5.55B
AUM Growth
+$502M
(+9.9%)
Cap. Flow
+$203M
Cap. Flow
% of AUM
3.66%
Top 10 Holdings %
Top 10 Hldgs %
19.68%
Holding
934
New
51
Increased
198
Reduced
144
Closed
33
Top Buys
| 1 |
Cintas
CTAS
|
+$23.7M |
| 2 |
Sunrun
RUN
|
+$18.3M |
| 3 |
Agios Pharmaceuticals
AGIO
|
+$14.6M |
| 4 |
NOVA
Sunnova Energy
NOVA
|
+$14M |
| 5 |
Home Depot
HD
|
+$13.5M |
Top Sells
| 1 |
Silicon Motion
SIMO
|
+$25.9M |
| 2 |
NVIDIA
NVDA
|
+$25.7M |
| 3 |
Visa
V
|
+$16.9M |
| 4 |
Comcast
CMCSA
|
+$16.5M |
| 5 |
TJX Companies
TJX
|
+$14.5M |
Sector Composition
| 1 | Technology | 31.13% |
| 2 | Healthcare | 18.95% |
| 3 | Consumer Discretionary | 13.96% |
| 4 | Financials | 9.3% |
| 5 | Industrials | 7.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
JNPR
326
DELISTED
Juniper Networks
JNPR
| $1.34M | 0.02% |
37,500
-6,700
| -15% | -$240K |
|
327
MetLife
MET
$52.9B
| $1.34M | 0.02% |
21,300
-4,500
| -17% | -$282K |
|
328
BioNTech
BNTX
$24.7B
| $1.33M | 0.02% |
5,500
| – | – |
|
329
Vir Biotechnology
VIR
$721M
| $1.3M | 0.02% |
33,300
| – | – |
|
330
Insmed
INSM
$31B
| $1.3M | 0.02% |
47,600
| – | – |
|
331
Enbridge
ENB
$105B
| $1.29M | 0.02% |
33,700
-2,000
| -6% | -$76.8K |
|
332
Schlumberger
SLB
$53.4B
| $1.28M | 0.02% |
+43,167
| New | +$1.28M |
|
333
Valero Energy
VLO
$48.9B
| $1.27M | 0.02% |
17,000
+9,000
| +113% | +$672K |
|
334
Tenaris
TS
$18.2B
| $1.26M | 0.02% |
60,000
| – | – |
|
335
Western Union
WU
$2.82B
| $1.25M | 0.02% |
69,900
+18,500
| +36% | +$331K |
|
336
Iovance Biotherapeutics
IOVA
$861M
| $1.24M | 0.02% |
64,000
| – | – |
|
337
Kodiak Sciences
KOD
$517M
| $1.21M | 0.02% |
13,700
| – | – |
|
338
Intellia Therapeutics
NTLA
$1.27B
| $1.17M | 0.02% |
9,845
+45
| +0.5% | +$5.33K |
|
339
Nucor
NUE
$33.1B
| $1.16M | 0.02% |
10,100
+7,600
| +304% | +$873K |
|
340
Aflac
AFL
$56.9B
| $1.16M | 0.02% |
19,700
-4,800
| -20% | -$282K |
|
341
Verisk Analytics
VRSK
$38.1B
| $1.14M | 0.02% |
5,000
-2,230
| -31% | -$509K |
|
342
Xenon Pharmaceuticals
XENE
$2.94B
| $1.1M | 0.02% |
+35,000
| New | +$1.1M |
|
343
Fidelity National Information Services
FIS
$36B
| $1.09M | 0.02% |
10,000
-2,086
| -17% | -$228K |
|
344
Travere Therapeutics
TVTX
$1.89B
| $1.09M | 0.02% |
35,600
| – | – |
|
|
ITCI
345
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.09M | 0.02% |
21,000
| – | – |
|
346
Wells Fargo
WFC
$254B
| $1.09M | 0.02% |
22,423
-158
| -0.7% | -$7.66K |
|
347
Zoetis
ZTS
$67.3B
| $1.07M | 0.02% |
4,348
+1,548
| +55% | +$380K |
|
348
Cytokinetics
CYTK
$6.23B
| $1.05M | 0.02% |
+22,600
| New | +$1.05M |
|
|
B
349
Barrick Mining Corporation
B
$49.5B
| $1.01M | 0.02% |
53,600
| – | – |
|
350
Goldman Sachs
GS
$225B
| $1M | 0.02% |
2,598
+59
| +2% | +$22.8K |
|